NEW YORK, June 5 – DeCode Genetics said Tuesday it has appointed Michael Young to the newly created position of vice president of business development.

In the new role, Young will be in charge of building the company’s corporate alliances for its research and product development programs.

Young, 49, previously worked at Genzyme Transgenics, where he was most recently vice president of commercial development. He has also worked as the head of business development at PerSeptive BioSystems and at Millipore.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new analysis examines the gender gap among paper authors in the sciences and says it may take decades or more to close.

Researchers have uncovered signals of selection that may enable the Bajau people to free five hundreds of feet deep, Reuters reports.

In Science this week: paternally inherited cis-regulatory structural variants in autism, and more.

A new report outlines issues facing the implementation of personalized medicine in the UK, the Independent reports.